Table 1.
Demographics.
| G-tube (n = 25) | No G-tube (n = 60) | P-value | |
|---|---|---|---|
| Category 1: non-modifiable risk factors | |||
| Birth weight ≥ 2500 g | 80% | 93% | 0.08 |
| Gestational age ≥ 36 weeks | 88% | 93% | 0.41 |
| Prenatal diagnosis | 72% | 47% | 0.06 |
| Female | 40% | 28% | 0.32 |
| Hispanic ethnicity | 20% | 23% | >0.99 |
| Apgar at 5 min ≥ 5 | 84% | 83% | 0.15 |
| Chromosomal anomaly | 4% | 5% | 0.79 |
| Congenital heart disease | 28% | 28% | >0.99 |
| Category 2: modifiable risk factors within first week | |||
| ECMO | 48% | 3% | <0.001 |
| Epinephrine | 76% | 42% | 0.01 |
| Nitric oxide | 84% | 40% | <0.001 |
| Repair by 1 week | 24% | 72% | <0.001 |
| Category 3: modifiable risk factors after first week | |||
| Proton pump inhibitor | 68% | 10% | <0.001 |
| H2 receptor antagonist | 76% | 37% | 0.002 |
| Sildenafil | 24% | 2% | 0.002 |
| Dexmedetomidine | 28% | 5% | 0.01 |
| Any maternal breast milk | 36% | 65% | 0.02 |
ECMO: extracorporeal membrane oxygenation; G-tube: gastrostomy tube.